Kewaunee Scientific Corporation
KEQU
$36.68
$0.110.30%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -7.45% | 3.32% | 46.75% | 46.93% | 36.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.45% | 3.32% | 46.75% | 46.93% | 36.06% |
| Cost of Revenue | -5.56% | 4.23% | 48.99% | 39.74% | 26.27% |
| Gross Profit | -11.62% | 0.90% | 41.34% | 67.60% | 64.19% |
| SG&A Expenses | 3.16% | -1.03% | 64.04% | 62.61% | 70.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.59% | 2.93% | 52.29% | 44.69% | 34.13% |
| Operating Income | -38.64% | 14.76% | -7.37% | 86.80% | 53.93% |
| Income Before Tax | -33.47% | 25.80% | -12.16% | 61.32% | 430.73% |
| Income Tax Expenses | -51.68% | 588.89% | -0.11% | 296.35% | 122.40% |
| Earnings from Continuing Operations | -25.37% | -22.20% | -15.82% | 41.15% | -55.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -213.40% | -1,224.14% | -1,228.57% | -46.67% | 36.60% |
| Net Income | -30.14% | -48.89% | -18.72% | 41.04% | -56.01% |
| EBIT | -38.64% | 14.76% | -7.37% | 86.80% | 53.93% |
| EBITDA | -30.88% | 9.60% | 8.53% | 87.58% | 54.46% |
| EPS Basic | -30.44% | -48.77% | -18.55% | 40.95% | -55.95% |
| Normalized Basic EPS | -39.21% | -19.30% | -15.52% | 61.65% | 36.76% |
| EPS Diluted | -30.73% | -48.89% | -18.81% | 40.54% | -56.06% |
| Normalized Diluted EPS | -39.23% | -19.15% | -16.16% | 61.99% | 36.15% |
| Average Basic Shares Outstanding | 0.42% | -0.21% | -0.21% | 0.07% | -0.14% |
| Average Diluted Shares Outstanding | 0.47% | -0.40% | 0.54% | -0.13% | 0.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |